The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBIDS.L Regulatory News (BIDS)

  • There is currently no data for BIDS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update - H2 2014 Sales up 495%

13 Feb 2015 07:00

RNS Number : 8132E
Fitbug Holdings PLC
13 February 2015
 

Fitbug Holdings Plc / Epic: FITB.L / Index: AIM / Sector: Leisure

 

13 February 2015

FITBUG HOLDINGS PLC

TRADING UPDATE - 2014 SECOND HALF SALES UP 495% ON PRIOR YEAR

 

 

Fitbug Holdings Plc, the AIM quoted provider of online personal health and wellbeing services, is pleased to provide an update on trading.

 

Overview

· Full year 2014 sales up 310% on prior year

· Second half 2014 sales up 495% on second half 2013

· Full year loss expected to be in line with management forecasts at £3.6m reflecting stronger second half sales offset by increased investment in Kiqplan development

· Strong pipeline of opportunities from Consumer Electronics Show ('CES')

· New retail opportunities with Amazon, Argos, and BestBuy.com announced

· Kiqplan's open platform approach attracting strong interest

· Development of four new Kiqplans on track for end March 2015 launch

· Successful December fundraising leaves Company better placed to support development

· Two senior appointments made to drive growth and development - Director of Marketing from Adidas and Head of Product

· Kiqplan connectivity to Apple HealthKit on track to support Apple Watch connectivity from April 2015 launch

 

Paul Landau, CEO of Fitbug Limited said "This is a really exciting period of opportunity for Fitbug as we see accelerating growth and convergence across the wearable tech, mobile and digital health landscape. Our new Kiqplan service proposition has been incredibly well received in the market and we are extremely excited by its potential as awareness and understanding of it grows."

 

2014 full year sales of £2.34m were 310% up on the prior year. Second half sales at £1.4m were stronger reflecting increased sales of the Fitbug Orb in the final quarter, particularly to Sainsbury's and Target.

 

The Consumer Electronics Show (CES) in January provided further evidence of the explosive global growth in wearable technology and provided a great platform to formally launch and demonstrate Kiqplan, the digital health coaching platform, to the trade. The reception from retailers, strategic/device partners and consumers has been really encouraging and the Company expects to be making a series of follow-up announcements over the coming months as these pipeline discussions are progressed to fruition.

 

Early partner response to our decision to develop Kiqplan as an open platform connecting to leading wearable devices and mobile phones is very encouraging. The Samsung S Health deal will help grow scale and Kiqplan brand equity whilst the recently announced collaboration with leading wearable company Jawbone should bring early commercial benefit. Further device partner discussions are in hand. Importantly we see the range of potential partners extending beyond wearable and mobile companies to include, for example, health insurers, health clubs, weight loss businesses, public health systems and other participants across the mHealth sector. The recent acquisitions of the MyFitnessPal and Endomondo Apps by sports clothing and accessories company Under Armour further reinforces the growing interest in data and open platform applications across a widening landscape.

 

Retail interest continues to grow. Early sales in Sainsbury's have been strong with almost all stock selling through in the Christmas and New Year sale period. Recent in store promotion activity in both Sainsbury's and Target stores have led to a strong uptake. The Fitbug Orb is now featured in the latest Argos catalogue. BestBuy.com sales had been delayed from January due to a switch to their preferred distributor and should now go live very shortly. Retailers are particularly interested by the opportunity that Kiqplan provides for additional sales within their wearables section. Amazon is emerging as one of the largest retailers of wearables and we are in discussions to extend our recent UK Amazon promotion to Amazon in the US.

 

As part of its marketing strategy Fitbug was pleased to agree a partnership with Cancer Research UK (CRUK) and to be their Official Fitness Partner of Race for Life for 2015, which includes their flagship event series. This partnership is in line with Fitbug's strategy to increase its market profile as it moves to scale up the business. We have also sold 1,000 Orbs to Weetabix as part of a promotion which will feature Fitbug on all Weetabix packs around Europe and the Middle East (excluding the UK).

 

Development of new Kiqplans are progressing well and the Company will have eight Kiqplans available for retail sale by the start of April 2015. Work is also nearing completion to develop enhanced Kiqplan packaging and Point of sale (POS) material to maximize consumer understanding and retail uptake. This will also be available from April 2015. In parallel we continue to improve the functionality of our products with new regular upgrade releases of the App to enhance the user experience. In developing Kiqplan the Company continues to get input from Fjord (part of Accenture Interactive) and Paul Landau has been invited by Accenture to the World Mobile Congress in Barcelona in March to showcase Kiqplan, and also present at HIMMS (Healthcare Information and Management Systems Society) in Chicago during April.

 

Development work to connect Kiqplan to Apple HealthKit is progressing well with the objective of ensuring that all Kiqplans can connect with Apple Watch from its expected launch date in April.

 

To strengthen the Fitbug senior team and help to more effectively manage the myriad of opportunities that are evident we have made two new senior appointments. Simon Breakell joins as Director of Marketing from Adidas where he worked for the last three years in a number of senior marketing roles, mainly focused on wearable technology and service products. Simon will manage all aspects of device and Kiqplan marketing including digital and social media. Anna Gusmundson joins at Interim Head of Product to help drive forward and extend the Kiqplan proposition. Anna is a product expert with more that ten years ROI driven product experience used to working in both start-ups and blue-chip companies. Most recently she has worked as an independent product strategy and process consultant, having previously served as Head of Services and Applications for a global mobile handset manufacturer.

 

Regarding its trademark dispute against Fitbit the Company is currently in discussions with its legal advisers regarding its options and will make a further announcement in due course. The Board would like to be clear that it will not allow this legal case to distract from the top priority of growing and developing the Fitbug business.

 

The successful fundraising in December leaves the Company better placed to build on recent successes and take advantage of emerging opportunities for the Fitbug Orb and Kiqplan in the growing wearable tech and software market. Current Orb stock levels are good leaving the Company well placed to support retail and B2B opportunities through the first half.

 

**ENDS**

 

For further information visit www.kiqplan.com or www.fitbugholdings.com contact:

 

Paul Landau/Andrew Brummer

Fitbug Holdings Plc

020 7449 1000

Mark Percy/Catherine Leftley

Cantor Fitzgerald Europe

020 7894 7000

Claire Louise Noyce / William Lynne / Niall Pearson

Hybridan LLP, Broker

0203 713 4580/4582/4583

Elisabeth Cowell/Charlotte Heap

St Brides Partners Ltd

020 7236 1177

 

Notes

About Fibtug®

Fitbug is a leading provider of online health and well-being services to help individuals to improve their lifestyles by making realistic changes to their daily routine. It combines activity tracking devices, which download to the Fitbug app and fitbug.com to provide an understanding of each user's daily activity achievements, with mobile and web technology which provides users with personalised weekly activity and nutrition targets, feedback, advice and encouragement.

 

Its "Kiqplan"TM digital health coaching platform is designed to make wearable technology relevant to new audiences and take the "so what?" out of activity tracking by providing structured action plans to help people get fitter, lighter and lead happier, healthier lives.

 

Key market sectors and distribution channels include retail, health insurance and rewards providers, workplace health programmes, fitness operators and consumers. An important part of the Company's focus is on building strategic partnerships with organisations which can integrate Fitbug or Kiqplan into their own service/product offerings or resell to their customer base. The Company has operations in the UK and United States. For more information, visit www.fitbug.com and www.kiqplan.com.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTZMGMZFZDGKZZ
Date   Source Headline
23rd Apr 20247:00 amRNSCancellation - Bidstack Group PLC
22nd Mar 20241:11 pmRNSAppointment of Administrators & Nomad Resignation
11th Mar 20247:30 amRNSSuspension - Bidstack Group PLC
11th Mar 20247:00 amRNSIntention to Appoint Administrators & Suspension
5th Feb 20247:00 amRNSUpdate on CLN, Financial Update & Strategic Review
22nd Dec 20237:00 amRNSSettlement & new commercial partnership - Azerion
1st Nov 20237:00 amRNSChange of Registered Office
18th Oct 20233:45 pmRNSProposed CLN, Share Reorganisation and VST Update
29th Sep 20237:00 amRNSBoard Change
29th Sep 20237:00 amRNSProposed New Commercial Partnership
29th Sep 20237:00 amRNSInterim Results
30th Aug 20237:00 amRNSVenatus Advertising Sales Partnership
23rd Aug 20234:47 pmRNSTR-1: Notification of Major Holdings
21st Jul 202311:23 amRNS2023 Annual General Meeting Results
18th Jul 202311:46 amRNSGeneral Meeting Requisition Request withdrawn
18th Jul 20237:00 amRNSBoard Changes
13th Jul 20231:32 pmRNSVirtual stadium partnership with first NFL team
11th Jul 20237:00 amRNSRequisitioned General Meeting
5th Jul 20237:00 amRNSRequest to requisition a General Meeting
21st Jun 20237:00 amRNSAnnual Report & Accounts and Notice of AGM
20th Jun 20238:18 amRNSFinal Results and Annual Report - replacement
20th Jun 20237:00 amRNSAnnual Report & Accounts and Notice of AGM
1st Mar 20235:28 pmRNSComment on Azerion Statement
15th Feb 20237:00 amRNSBidstack appoints Thomas Bullen as CFO
13th Feb 20232:05 pmRNSSecond Price Monitoring Extn
13th Feb 20232:00 pmRNSPrice Monitoring Extension
13th Feb 20237:00 amRNSTrading and Operational Update
18th Jan 202311:22 amRNSChange of Registered Office
3rd Jan 202311:05 amRNSSecond Price Monitoring Extn
3rd Jan 202311:00 amRNSPrice Monitoring Extension
3rd Jan 20237:00 amRNSAzerion Update
29th Dec 20227:00 amRNSBoard Changes
9th Dec 202211:04 amRNSGrant of LTIP Options
8th Dec 20227:00 amRNSExercise of Options, Issue of Equity & TVR
6th Dec 202211:03 amRNSTR-1: Notification of major holdings
5th Dec 20227:00 amRNSBidstack adds 2 titles with a AAA game publisher
1st Nov 20223:39 pmRNSTR-1: Notification of major holdings
31st Oct 20223:35 pmRNSTotal Voting Rights
31st Oct 20223:21 pmRNSTR-1: Notification of major holdings
31st Oct 20222:16 pmRNSTR-1: Notification of major holdings
31st Oct 202211:54 amRNSTR-1: Notification of major holdings
28th Oct 20224:16 pmRNSTR-1: Notification of Major Holdings
28th Oct 20227:00 amRNSUpdate re Press Commentary
26th Oct 20223:45 pmRNSAdmission of Ordinary Shares and TVR
26th Oct 20227:00 amRNSStrategy Update
25th Oct 202212:08 pmRNSResults of General Meeting
13th Oct 20227:00 amRNSBidstack appoints Camila Franklin as COO
6th Oct 20226:28 pmRNSResults of REX Retail Offer
6th Oct 20228:06 amRNSResults of Placing and Subscription
5th Oct 20224:36 pmRNSREX Retail Offer

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.